Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
Zafgen, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Coffs Harbour Gp Superclinic
Coffs Harbour, New South Wales, Australia
- Northside Health
Coffs Harbour, New South Wales, Australia
- the Aim Centre
Merewether, New South Wales, Australia
- Holdsworth House Medical Practice
Sydney, New South Wales, Australia
- Pendlebury Research
Sydney, New South Wales, Australia
- the Boden Institute
Sydney, New South Wales, Australia
- Q-Pharm
Herston, Queensland, Australia
- Griffith University, Gold Coast Campus
Southport, Queensland, Australia
- Southern Adelaide Diabetes & Endocrine Services
Daw Park, South Australia, Australia
- Eastern Clinical Research Unit (ecru)
Box Hill, Victoria, Australia
- Barwon Health
Geelong, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Middlemore Hospital
Auckland, New Zealand
- Optimal Clinical Trials
Auckland, New Zealand
- Christchurch Diabetes Centre
Christchurch, New Zealand
- Lipid and Diabetes Research Group
Christchurch, New Zealand
- Southern Clinical Trials
Christchurch, New Zealand
- Clinical Trials New Zealand Ltd
Hamilton, New Zealand
- P3 Research Hawkes Bay
Hastings, New Zealand
- P3 Research Wellington
Newtown, New Zealand
- Lakeland Clinical Trials
Rotorua, New Zealand
- P3 Research Tauranga
Tauranga, New Zealand
- Wellington Hospital
Wellington, New Zealand
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Sept 2017
- Primary completion
- 12 Nov 2018
- Completion
- 22 Feb 2019
- Last update posted
- 24 May 2019
- Registered enrollment
- 188
- Registry id
- NCT03254368
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.